Polen Capital, a well-regarded investment management firm, has released its Q3 2026 investor letter for its ‘5Perspectives Growth Opportunities Strategy’. This document details the portfolio’s performance, which saw a 6.2% decline during the third quarter of 2026. This performance lagged behind the Russell 3000 Growth Index, which posted a modest gain of 0.5% over the same period. The portfolio’s relative performance was bolstered by investments in companies like Twist Bioscience and CrowdStrike, as well as a strategic underweight position in Micron Technology. However, investments in Argan, Inc., an underweight position in Microsoft, and Bloom Energy negatively impacted the portfolio’s results. Despite the volatility observed in the market, Polen Capital remains optimistic about the underlying fundamentals of artificial intelligence (AI). The firm is gradually shifting its investment focus from AI infrastructure providers to companies that are utilizing AI to increase productivity and create innovative new products.
Argan, Inc. (NYSE:AGX) was highlighted in Polen Capital’s investor letter. The company is known for providing engineering, procurement, construction, and technical services, primarily to the power generation and renewable energy sectors. As of November 3, 2026, Argan’s shares closed at $348.24, with a market capitalization of $4.34 billion. Over the past month, Argan’s stock has experienced a decline of 23.71%, which has contributed to a 5.06% decrease over the past year.
Polen Capital’s letter elaborated on the performance of Argan, noting that the company’s shares underperformed during the quarter despite reporting record fiscal second-quarter earnings. Investors’ attention was drawn to a reduction in Argan’s backlog, which decreased from $2.9 billion to $2.5 billion. This decline was attributed to the absence of any significant new power projects being awarded during the period. Additionally, the industrial segment’s margins fell short of expectations due to cost overruns on several non-data-center projects. These issues, combined with a substantial increase in the stock price earlier in the year, led investors to scrutinize the timing of new project awards and the sustainability of profit margins.
Argan, Inc. is not listed among the top 40 most popular stocks among hedge funds, according to available data. At the end of the second quarter, 39 hedge fund portfolios included Argan, down from 42 in the previous quarter. While Argan holds potential as an investment, Polen Capital suggests that certain AI stocks may offer greater upside potential and pose less downside risk. Investors interested in undervalued AI stocks that could benefit from Trump-era tariffs and the onshoring trend are encouraged to review Polen Capital’s free report on promising short-term AI investment opportunities.
Argan, Inc. has been featured in discussions about the best-performing stocks over the last two decades. For more insights from hedge fund investor letters for Q3 2026, readers are directed to Polen Capital’s investor letters page. These letters provide a comprehensive view of the strategies and stock selections that are shaping the firm’s investment decisions.
Investors and analysts alike are closely watching how Argan, Inc. will navigate the challenges posed by its current backlog and margin issues. The company’s ability to secure new projects and maintain profitability will be crucial in determining its future stock performance. As the market continues to evolve, Argan’s strategic decisions and operational efficiency will play a pivotal role in its long-term success. Meanwhile, the broader market’s focus on AI and technological advancements presents both challenges and opportunities for companies like Argan, which operate in the engineering and construction sectors.
Footnotes:
- Polen Capital’s Q3 2026 investor letter reported a portfolio decline of 6.2% compared to the Russell 3000 Growth Index’s 0.5% gain. Source.
- Argan’s backlog decreased from $2.9 billion to $2.5 billion, with no major new power projects awarded. Source.
- Argan, Inc. is not among the top 40 stocks held by hedge funds, with 39 portfolios holding it at the end of Q2 2026. Source.
Featured Image: DepositPhotos @ meteor.jpg
